drugset / Trial / NCT00364039

Study to Examine the Safety, Tolerability, and Pharmacokinetics of AV650

NCT00364039

Phase 1 Completed 30 enrolled Avigen
RandomizedParallel-groupDouble-blind

Summary

The purpose of this study is to determine the safety and tolerability of AV650 in healthy subjects given single and multi-doses under fasted and fed conditions.

Timeline

Start
2006-08
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject AV650 Unknown

Indications

No indication recorded.